﻿<?xml version="1.0" encoding="utf-8"?>
<Return xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2016v3.0" xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2017-09-06T15:12:34-05:00</ReturnTs>
    <TaxPeriodEndDt>2016-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>271728945</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>PKF O'CONNOR DAVIES LLP</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>665 FIFTH AVENUE</AddressLine1Txt>
        <CityNm>NEW YORK</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>10022</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2016-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>133859563</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>THE ZACHARY &amp; ELIZABETH M FISHER CENTER</BusinessNameLine1Txt>
        <BusinessNameLine2Txt>FOR ALZHEIMER'S RESEARCH FOUNDATION</BusinessNameLine2Txt>
      </BusinessName>
      <BusinessNameControlTxt>ZACH</BusinessNameControlTxt>
      <PhoneNum>2129151321</PhoneNum>
      <USAddress>
        <AddressLine1Txt>110 EAST 42ND STREET NO 16 FL</AddressLine1Txt>
        <CityNm>NEW YORK</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>10017</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>KENT KAROSEN</PersonNm>
      <PersonTitleTxt>PRESIDENT &amp; CEO</PersonTitleTxt>
      <PhoneNum>2129151321</PhoneNum>
      <SignatureDt>2017-09-06</SignatureDt>
      <DiscussWithPaidPreparerInd>1</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>GARRETT M HIGGINS</PreparerPersonNm>
      <PTIN>P00543209</PTIN>
      <PhoneNum>2122862600</PhoneNum>
      <PreparationDt>2017-09-06</PreparationDt>
    </PreparerPersonGrp>
    <FilingSecurityInformation>
      <IPAddress>
        <IPv4AddressTxt>65.51.112.58</IPv4AddressTxt>
      </IPAddress>
      <IPDt>2017-09-06</IPDt>
      <IPTm>15:33:27</IPTm>
      <IPTimezoneCd>ED</IPTimezoneCd>
      <FilingLicenseTypeCd>P</FilingLicenseTypeCd>
      <AtSubmissionCreationDeviceId>8A2132EDD6189675F9F87A04A1E474E8E200C641</AtSubmissionCreationDeviceId>
      <AtSubmissionFilingDeviceId>F815E433DFD393C44755F4EA77CCA1D41B0E4C94</AtSubmissionFilingDeviceId>
    </FilingSecurityInformation>
    <TaxYr>2016</TaxYr>
    <BuildTS>2021-01-29 14:40:06Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="10">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <DoingBusinessAsName>
        <BusinessNameLine1Txt>ALZHEIMER'S RESEARCH FDNFISHER CTR</BusinessNameLine1Txt>
      </DoingBusinessAsName>
      <PrincipalOfficerNm>KENT KAROSEN</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>110 EAST 42ND STREET NO 16 FL</AddressLine1Txt>
        <CityNm>NEW YORK</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>10017</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>16806671</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>0</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.ALZINFO.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1995</FormationYr>
      <LegalDomicileStateCd>NY</LegalDomicileStateCd>
      <ActivityOrMissionDesc>SEE SCHEDULE O.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>15</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>13</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>8</TotalEmployeeCnt>
      <TotalVolunteersCnt>14</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>0</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>3414828</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>4376335</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>0</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>0</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>771257</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>552782</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>0</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>2156</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>4186085</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>4931273</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>2625000</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>6744376</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>900659</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>909840</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>0</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>241588</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>518436</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>458435</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>4044095</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>8112651</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>141990</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>-3181378</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>22274437</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>23863565</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>120896</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>4718230</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>22153541</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>19145335</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>SEE SCHEDULE O.THE ZACHARY AND ELIZABETH M. FISHER ALZHEIMER'S RESEARCH FOUNDATION IS DEDICATED TO ATTACKING THE SCOURGE OF ALZHEIMER'S DISEASE THROUGH A 3-PRONGED ASSAULT FOCUSED ON UNDERSTANDING THE CAUSE OF ALZHEIMER'S DISEASE; IMPROVING THE CARE OF PEOPLE LIVING WITH THE DISEASE TO ENHANCE THEIR QUALITY OF LIFE AND THAT OF THEIR CAREGIVERS AND FAMILIES; AND FINDING A CURE FOR THIS DEVASTATING DISEASE.</MissionDesc>
      <SignificantNewProgramSrvcInd>0</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>0</SignificantChangeInd>
      <ExpenseAmt>7000000</ExpenseAmt>
      <GrantAmt>6594376</GrantAmt>
      <Desc>A GRANT OF $2,000,000 WAS AWARDED TO THE FISHER CENTER RESEARCH LABORATORY AT THE ROCKEFELLER UNIVERSITY TO CONTINUE OUR INVESTIGATIONS INTO THE CURE OF ALZHEIMER'S UNDER THE DIRECTION OF NOBEL LAUREATE DR. PAUL GREENGARD AND OVER 50 INTERNATIONALLY RENOWNED SCIENTISTS. A ONE-TIME GRANT OF $5,000,000, PAYABLE OVER 7 YEARS, WAS MADE TO THE ROCKEFELLER UNIVERSITY TO ESTABLISH THE PAUL GREENGARD PROFESSORSHIP IN NEUROSCIENCE FOCUSING ON ALZHEIMER'S DISEASE, TO MAINTAIN OUR CONTINUITY OF SUPPORTING THE OUTSTANDING RESEARCH BY THE FISHER CENTER AND TO CONTINUE OUR DEDICATION IN THE FIGHT AGAINST ALZHEIMER'S. (SEE SCHEDULE O FOR FURTHER INFORMATION ON BOTH.) A GRANT WAS MADE TO THE FISHER CENTER FOR ALZHEIMER'S RESEARCH AT THE ROCKEFELLER UNIVERSITY FOR NEUROLOGICAL RESEARCH INTO THE CAUSES OF ALZHEIMER'S AND POTENTIAL NEW PHARMACOLOGICAL TREATMENT OPTIONS. THE LAB IS UNDER THE DIRECTION OF NOBEL LAUREATE DR. PAUL GREENGARD WHO HEADS A TEAM OF OVER 50 INTERNATIONALLY RENOWNED SCIENTISTS. HIS SEMINAL FINDINGS HAVE BEEN THE BASIS OF MANY OF TODAY'S ALZHEIMER'S INVESTIGATIONS WORLDWIDE.IN 2016, FISHER SCIENTISTS INVESTIGATED THE POSSIBILITY THAT AN EARLY TRAFFICKING STEP, INVOLVING COPI-DEPENDENT TRAFFICKING, COULD BE RELEVANT FOR AMYLOID PRECURSOR PROTEIN (APP) MATURATION AND FOR ALZHEIMER'S DISEASE (AD). THEIR STUDIES DEMONSTRATE THAT THE COPI COMPLEX REGULATES APP INTRACELLULAR TRAFFICKING, CONTROLLING ITS SUBCELLULAR LOCALIZATION, CELL SURFACE EXPRESSION, MATURATION AND MORE IMPORTANTLY THE PRODUCTION OF A? PEPTIDES. IN SEPARATE RESEARCH, FISHER CENTER SCIENTISTS IDENTIFIED GENETIC MARKERS AND SPECIFIC DIFFERENCES IN COPI GENES LINKED WITH AN INCREASED AD RISK. ALL TOGETHER, THESE RESULTS DEMONSTRATE IN VIVO THE IMPORTANCE OF COPI AND EARLY TRAFFICKING STEPS IN AD, AND THE RELEVANCE OF COPI COMPLEX IN THE CONTEXT OF AD PATIENTS.THE SCIENTISTS ALSO USED IDISCO, A NEW IMAGE METHODOLOGY INVOLVING TARGETED MOLECULAR LABELING, TISSUE CLEARING AND LIGHT-SHEET MICROSCOPY TO GAIN UNPRECEDENTED ACCESS TO THE INTACT AD MOUSE BRAIN AND TO STUDY PLAQUE FORMATION IN ANIMALS. THEY ARE NOW ABLE TO VISUALIZE AMYLOID PLAQUES AND VIEW OTHER PARAMETERS SUCH AS TAU, MICROGLIA CELLS AND VASCULATURE. THIS IS THE FIRST TIME THAT IT IS POSSIBLE TO FOLLOW THREE PARAMETERS AT ONCE IN 3D AND IN A FULL MOUSE BRAIN. FISHER SCIENTISTS CONTINUED THEIR EFFORT TO SYNTHESIZE DERIVATIVES OF GLEEVEC AND SCREEN THE DERIVATIVES FOR MORE POTENT BETA-AMYLOID LOWERING ACTIVITY AND THE ABILITY TO ACCUMULATE IN THE BRAIN WITHOUT BEING PUMPED OUT BY THE BLOOD-BRAIN-BARRIER. THEY HAVE DESIGNED, GENERATED AND PURIFIED OVER 130 GLEEVEC DERIVATIVES. INDEPENDENT OF THIS EFFORT, MUTATIONS THAT PROTECT PEOPLE FROM DEVELOPING AD HAVE BEEN DESCRIBED IN THE LITERATURE. INTERESTINGLY, SOME OF THE GLEEVEC DERIVATIVES NEWLY SYNTHETIZED MIGHT MIMIC THE EFFECT OF ONE SUCH PROTECTIVE MUTATION. THE CELLULAR PROCESS RESPONSIBLE FOR THE MUTATION'S PROTECTIVE EFFECT WAS ALSO IDENTIFIED, SUGGESTING THAT DRUGS TARGETING THIS PROCESS OR PATHWAY MIGHT ALSO PROVIDE PROTECTION AGAINST THE DEVELOPMENT OF AD. IN OTHER RESEARCH, THE SCIENTISTS ACCELERATED THE BREAKDOWN OF BETA-AMYLOID. THE UNDERLYING CELLULAR PROCESS IS CALLED AUTOPHAGY, A BIOLOGICAL SYSTEM RESPONSIBLE FOR REMOVING DEBRIS FROM THE CELLS, INCLUDING UNWANTED MATERIALS SUCH AS THE PROTEIN AGGREGATES THAT ARE HALLMARKS OF ALZHEIMER'S DISEASE. FISHER SCIENTISTS DISCOVERED A COMPOUND CALLED SMER28 WHICH LOWERS THE LEVEL OF BETA-AMYLOID FOUND IN NERVE CELLS BY STIMULATING AUTOPHAGY. ALONG THOSE LINES, THE SCIENTISTS IDENTIFIED A COMPLETELY NOVEL SIGNALING NETWORK WITHIN NEURONS THAT REGULATES BETA-AMYLOID DEGRADATION AND METABOLISM. FURTHERMORE, THEY DEMONSTRATED THAT THE PHOSPHORYLATION OF PS1 BY THE PROTEIN KINASE CK1 PARTICIPATES IN THE DEGRADATION OF INTRACELLULAR MATERIAL.LASTLY, IN AN EFFORT TO UNDERSTAND WHY SOME BRAIN REGIONS ARE MORE VULNERABLE TO THE DISEASE EARLY ON IN THE PROCESS (E.G. ENTORHINAL CORTEX), FISHER CENTER SCIENTISTS DISCOVERED A PROTEIN THEY NAMED ADV1, WHICH IS PRESENT IN MUCH LARGER QUANTITY IN THE ENTORHINAL CORTEX, AND THAT MIGHT MAKE THIS PART OF THE BRAIN MORE FRAGILE. ADV1 COULD REPRESENT AN ENTIRELY NEW THERAPEUTIC STRATEGY TO SPECIFICALLY PREVENT ENTORHINAL CORTEX NEURONS DEGENERATION.A GRANT WAS MADE TO THE ROCKEFELLER UNIVERSITY TO ESTABLISH THE PAUL GREENGARD PROFESSORSHIP IN NEUROSCIENCE TO RECOGNIZE NOBEL LAUREATE DR. PAUL GREENGARD, DIRECTOR OF THE FISHER CENTER FOR ALZHEIMER'S RESEARCH FOUNDATION AND HIS MANY YEARS OF DEDICATION IN THE FIGHT AGAINST ALZHEIMER'S. THE PURPOSE OF THE GREENGARD PROFESSORSHIP IS TO ENSURE A CONTINUED COMMITMENT TO THE OUTSTANDING RESEARCH BY THE FISHER CENTER FOR ALZHEIMER'S RESEARCH LAB. THE PROFESSORSHIP, ESTABLISHED IN PERPETUITY, WILL BE HELD BY AN OUTSTANDING SENIOR SCIENTIST AT THE ROCKEFELLER UNIVERSITY WORKING IN THE FIELD OF ALZHEIMER'S RESEARCH. THE $5 MILLION GRANT WILL BE PAID TO THE ROCKEFELLER UNIVERSITY OVER 7 YEARS.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>493739</ExpenseAmt>
        <Desc>THE FISHER CENTER ALZHEIMER'S INFORMATION PROGRAM PROMOTES PUBLIC AWARENESS AND EDUCATION ABOUT ALZHEIMER'S AND INFORMATION ON CAREGIVING. THE PROGRAM USES BOTH ONLINE AND TRADITIONAL MEDIA CONDUITS TO KEEP THE PUBLIC INFORMED WITH COMPREHENSIVE INFORMATION ABOUT ALZHEIMER'S, RECENT RESEARCH STUDIES, TREATMENTS AND DISEASE MANAGEMENT APPROACHES THROUGH ITS PUBLICATION, PRESERVING YOUR MEMORY MAGAZINE (CIRCULATION: 60,000; PUBLISHED THREE TIMES A YEAR, WITH AN ESTIMATED READERSHIP OF 2.8 MILLION ANNUALLY), WHICH IS DISTRIBUTED TO HEALTH CARE AND COMMUNITY ORGANIZATIONS NATIONWIDE. THE FISHER CENTER FOR ALZHEIMER'S RESEARCH FOUNDATION HAS A WEBSITE (ALZINFO.ORG) AND DISTRIBUTES BIWEEKLY E-NEWSLETTERS OF EXPERT-REVIEWED ALZHEIMER'S NEWS AND RESEARCH TO OVER 15,000 SUBSCRIBERS. THE WEBSITE IS UPDATED REGULARLY WITH FRESH CONTENT ON ALZHEIMER'S, CAREGIVING AND RESEARCH. IN 2016, THE WEBSITE HAD 835,518 UNIQUE VISITORS.THE FOUNDATION ALSO PUBLISHED A NEW BOOK, "WHY CAN'T GRANDMA REMEMBER MY NAME?", WRITTEN BY FOUNDATION PRESIDENT KENT L. KAROSEN AND CO-AUTHORED BY CHANA STIEFEL. THE BOOK EXPLAINS ALZHEIMER'S DISEASE BY INTEGRATING ARTWORK CREATED BY CHILDREN JUXTAPOSED WITH ART CREATED BY ALZHEIMER'S PATIENTS, DEMONSTRATING THE POWER OF ART THERAPY FOR ALL AGES AND A WAY FOR PARENTS AND FAMILY TO SHARE WITH A YOUNGER AUDIENCE WHAT IS HAPPENING TO GRANDMA OR OTHER LOVED ONES.</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <ExpenseAmt>100000</ExpenseAmt>
        <GrantAmt>100000</GrantAmt>
        <Desc>A GRANT WAS MADE TO THE FISHER EDUCATION AND RESOURCES PROGRAM AT NYU LANGONE SCHOOL OF MEDICINE FOR CLINICAL RESEARCH INTO THE EFFICACY OF BOTH PHARMACOLOGICAL AND NON-PHARMACOLOGICAL TREATMENT OPTIONS FOR ALZHEIMER'S DISEASE. THE CENTER IS UNDER THE DIRECTION OF DR. BARRY REISBERG, M.D., INTERNATIONALLY KNOWN EXPERT IN THE CARE OF ALZHEIMER'S PATIENTS. THE TOOLS AND SCALES FOR RESEARCH EVALUATION AND DISEASE MANAGEMENT DEVELOPED BY THIS PROGRAM ARE USED IN CARE SETTINGS AROUND THE WORLD. DR. REISBERG AND HIS COLLEAGUES AT THE CENTER HAVE PUBLISHED NUMEROUS ARTICLES ON BEST CARE MODALITIES THAT MAY SLOW THE PROGRESSION AND IMPROVE THE QUALITY OF LIFE FOR THOSE WITH ALZHEIMER'S. IN 2016, THE RESEARCHERS COMPLETED A NEW STATISTICAL ANALYSIS OF ITS DATA FOR THE COMPREHENSIVE INDIVIDUALIZED PERSON-CENTERED MANAGEMENT PROGRAM (CI-PCM) AND INCLUDED THEM IN "COMPREHENSIVE INDIVIDUALIZED PERSON-CENTERED MANAGEMENT OF COMMUNITY-RESIDING PERSONS WITH MODERATE-TO-SEVERE ALZHEIMER'S DISEASE: A RANDOMIZED CONTROLLED TRIAL." MEANWHILE, THE RESEARCHERS PUBLISHED A SEMINAL PAPER ENTITLED "ECOPSYCHOSOCIAL INTERVENTIONS IN COGNITIVE DECLINE AND DEMENTIA: A NEW TERMINOLOGY AND A NEW PARADIGM." THE NEW TERMINOLOGY HAS IMPROVED RECOGNITION OF PSYCHOSOCIAL THERAPIES (NON-PHARMACOLOGIC TREATMENTS) FOR AD. THEY ALSO WROTE A 59-PAGE CHAPTER ENTITLED "ALZHEIMER'S DISEASE," WHICH WAS PUBLISHED IN JANUARY 2017 IN THE 5TH EDITION OF THE TEXTBOOK "MEDICAL ASPECTS OF DISABILITY." THE CHAPTER COMPREHENSIVELY DESCRIBES THE NATURE AND THE SYMPTOMS OF ALZHEIMER'S DISEASE AS WELL AS THE SCIENCE OF MANAGEMENT.</Desc>
      </ProgSrvcAccomActy3Grp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>50000</ExpenseAmt>
        <GrantAmt>50000</GrantAmt>
        <Desc>THE FOUNDATION PROMOTES OTHER SERVICES AND EDUCATIONAL AWARENESS ACTIVITIES TO SERVE THE ALZHEIMER'S COMMUNITY. THIS INCLUDES A GRANT TO KAROLINSKA INSTITUTE IN SWEDEN FOR RESEARCH INTO THE CAUSE AND TREATMENT OF NEUROLOGICAL DISORDERS SUCH AS ALZHEIMER'S.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <TotalOtherProgSrvcExpenseAmt>50000</TotalOtherProgSrvcExpenseAmt>
      <TotalOtherProgSrvcGrantAmt>50000</TotalOtherProgSrvcGrantAmt>
      <TotalProgramServiceExpensesAmt>7643739</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc1039100001">1</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="RetDoc1234500001">1</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>0</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>0</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>0</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc1040000001">0</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc1040000001">0</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc1040000001">0</CreditCounselingInd>
      <TempOrPermanentEndowmentsInd referenceDocumentId="RetDoc1040000001">0</TempOrPermanentEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc1040000001">1</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc1040000001">0</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc1040000001">0</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc1040000001">0</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc1040000001">0</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc1040000001">1</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">1</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">0</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>0</SchoolOperatingInd>
      <ForeignOfficeInd>0</ForeignOfficeInd>
      <ForeignActivitiesInd referenceDocumentId="RetDoc1040500001">1</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd referenceDocumentId="RetDoc1040500001">1</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd referenceDocumentId="RetDoc1040500001">0</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>0</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>0</FundraisingActivitiesInd>
      <GamingActivitiesInd>0</GamingActivitiesInd>
      <OperateHospitalInd>0</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="RetDoc1041900001">1</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="RetDoc1041900001">0</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="RetDoc1042400001">1</ScheduleJRequiredInd>
      <TaxExemptBondsInd>0</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd referenceDocumentId="RetDoc1042800001">0</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd referenceDocumentId="RetDoc1042800001">0</PYExcessBenefitTransInd>
      <LoanOutstandingInd referenceDocumentId="RetDoc1042800001">0</LoanOutstandingInd>
      <GrantToRelatedPersonInd referenceDocumentId="RetDoc1042800001">0</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd referenceDocumentId="RetDoc1042800001">0</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd referenceDocumentId="RetDoc1042800001">0</BusinessRlnWithFamMemInd>
      <BusinessRlnWithOfficerEntInd referenceDocumentId="RetDoc1042800001">1</BusinessRlnWithOfficerEntInd>
      <DeductibleNonCashContriInd referenceDocumentId="RetDoc1042900001">1</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd referenceDocumentId="RetDoc1042900001">0</DeductibleArtContributionInd>
      <TerminateOperationsInd>0</TerminateOperationsInd>
      <PartialLiquidationInd>0</PartialLiquidationInd>
      <DisregardedEntityInd>0</DisregardedEntityInd>
      <RelatedEntityInd>0</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>0</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>0</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>0</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>1</ScheduleORequiredInd>
      <IRPDocumentCnt>3</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <EmployeeCnt>8</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>1</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>0</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>0</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>0</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>0</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>0</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>0</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>0</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>0</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>0</IndoorTanningServicesInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>15</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>13</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>1</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>0</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>0</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>0</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>0</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>0</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>0</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>1</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>1</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>0</OfficerMailingAddressInd>
      <LocalChaptersInd>0</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>1</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>1</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>1</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>1</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>1</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>1</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>1</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>1</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>0</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>AZ</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>CT</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>UT</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>IL</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MO</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MT</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NJ</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NY</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NC</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>OH</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>PA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>RI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>TX</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>VA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>WA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>WI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>CA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MD</StatesWhereCopyOfReturnIsFldCd>
      <OwnWebsiteInd>X</OwnWebsiteInd>
      <OtherWebsiteInd>X</OtherWebsiteInd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <BusinessName>
          <BusinessNameLine1Txt>FEKADU TADDESE</BusinessNameLine1Txt>
        </BusinessName>
        <PhoneNum>2129151324</PhoneNum>
        <USAddress>
          <AddressLine1Txt>110 EAST 42ND STREET FL 16</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10017</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>BARRY SLOANE</PersonNm>
        <TitleTxt>CHAIRMAN/TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>HOWARD LUTNICK</PersonNm>
        <TitleTxt>CO-VICE CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MARTIN EDELMAN</PersonNm>
        <TitleTxt>CO-VICE CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KENT KAROSEN</PersonNm>
        <TitleTxt>PRESIDENT/CEO</TitleTxt>
        <AverageHoursPerWeekRt>30.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>283329</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MURRAY RUBIN</PersonNm>
        <TitleTxt>SECRETARY</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR MANNY ALVAREZ</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR E RATCLIFFE ANDERSON JR</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>GERRY BYRNE</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>HADLEY FISHER</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>BETSY GOTBAUM</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR PAUL GREENGARD</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JAMES L NEDERLANDER</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>RICHARD J SALEM</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR MOSHE SHIKE</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DAVID HW TURNER</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>CORY RYAN</PersonNm>
        <TitleTxt>SENIOR VICE PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>104801</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>14962</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>388130</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>0</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>14962</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>2</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>0</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>1</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>0</CompensationFromOtherSrcsInd>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>THE STAYWELL COMPANY LLC</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>407 NORWALK STREET</AddressLine1Txt>
            <CityNm>GREENSBORO</CityNm>
            <StateAbbreviationCd>NC</StateAbbreviationCd>
            <ZIPCd>27407</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>MAGAZINE PUBLISHING</ServicesDesc>
        <CompensationAmt>193882</CompensationAmt>
      </ContractorCompensationGrp>
      <CntrctRcvdGreaterThan100KCnt>1</CntrctRcvdGreaterThan100KCnt>
      <FederatedCampaignsAmt>367184</FederatedCampaignsAmt>
      <AllOtherContributionsAmt>4009151</AllOtherContributionsAmt>
      <NoncashContributionsAmt>153485</NoncashContributionsAmt>
      <TotalContributionsAmt>4376335</TotalContributionsAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>349382</TotalRevenueColumnAmt>
        <ExclusionAmt>349382</ExclusionAmt>
      </InvestmentIncomeGrp>
      <RoyaltiesRevenueGrp>
        <TotalRevenueColumnAmt>820</TotalRevenueColumnAmt>
        <ExclusionAmt>820</ExclusionAmt>
      </RoyaltiesRevenueGrp>
      <GrossAmountSalesAssetsGrp>
        <SecuritiesAmt>12078798</SecuritiesAmt>
      </GrossAmountSalesAssetsGrp>
      <LessCostOthBasisSalesExpnssGrp>
        <SecuritiesAmt>11875398</SecuritiesAmt>
      </LessCostOthBasisSalesExpnssGrp>
      <GainOrLossGrp>
        <SecuritiesAmt>203400</SecuritiesAmt>
      </GainOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>203400</TotalRevenueColumnAmt>
        <ExclusionAmt>203400</ExclusionAmt>
      </NetGainOrLossInvestmentsGrp>
      <OtherRevenueMiscGrp>
        <Desc>MISCELLANEOUS REVENUE</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>1336</TotalRevenueColumnAmt>
        <ExclusionAmt>1336</ExclusionAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueTotalAmt>1336</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>4931273</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>0</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>554938</ExclusionAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>6694376</TotalAmt>
        <ProgramServicesAmt>6694376</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <ForeignGrantsGrp>
        <TotalAmt>50000</TotalAmt>
        <ProgramServicesAmt>50000</ProgramServicesAmt>
      </ForeignGrantsGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>283329</TotalAmt>
        <ProgramServicesAmt>212497</ProgramServicesAmt>
        <ManagementAndGeneralAmt>28333</ManagementAndGeneralAmt>
        <FundraisingAmt>42499</FundraisingAmt>
      </CompCurrentOfcrDirectorsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>536973</TotalAmt>
        <ProgramServicesAmt>342281</ProgramServicesAmt>
        <ManagementAndGeneralAmt>67550</ManagementAndGeneralAmt>
        <FundraisingAmt>127142</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>6018</TotalAmt>
        <ProgramServicesAmt>3836</ProgramServicesAmt>
        <ManagementAndGeneralAmt>757</ManagementAndGeneralAmt>
        <FundraisingAmt>1425</FundraisingAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>46292</TotalAmt>
        <ProgramServicesAmt>29508</ProgramServicesAmt>
        <ManagementAndGeneralAmt>5823</ManagementAndGeneralAmt>
        <FundraisingAmt>10961</FundraisingAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>37228</TotalAmt>
        <ProgramServicesAmt>23730</ProgramServicesAmt>
        <ManagementAndGeneralAmt>4683</ManagementAndGeneralAmt>
        <FundraisingAmt>8815</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>22000</TotalAmt>
        <ManagementAndGeneralAmt>22000</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForSrvcInvstMgmntFeesGrp>
        <TotalAmt>50307</TotalAmt>
        <ManagementAndGeneralAmt>50307</ManagementAndGeneralAmt>
      </FeesForSrvcInvstMgmntFeesGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>225259</TotalAmt>
        <ProgramServicesAmt>225259</ProgramServicesAmt>
      </FeesForServicesOtherGrp>
      <AdvertisingGrp>
        <TotalAmt>13095</TotalAmt>
        <FundraisingAmt>13095</FundraisingAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>66871</TotalAmt>
        <ProgramServicesAmt>11743</ProgramServicesAmt>
        <ManagementAndGeneralAmt>19640</ManagementAndGeneralAmt>
        <FundraisingAmt>35488</FundraisingAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>21049</TotalAmt>
        <ProgramServicesAmt>21049</ProgramServicesAmt>
      </InformationTechnologyGrp>
      <TravelGrp>
        <TotalAmt>39856</TotalAmt>
        <ProgramServicesAmt>26463</ProgramServicesAmt>
        <ManagementAndGeneralAmt>11230</ManagementAndGeneralAmt>
        <FundraisingAmt>2163</FundraisingAmt>
      </TravelGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>533</TotalAmt>
        <ManagementAndGeneralAmt>533</ManagementAndGeneralAmt>
      </ConferencesMeetingsGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>1223</TotalAmt>
        <ManagementAndGeneralAmt>1223</ManagementAndGeneralAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>9803</TotalAmt>
        <ManagementAndGeneralAmt>9803</ManagementAndGeneralAmt>
      </InsuranceGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>8439</TotalAmt>
        <ProgramServicesAmt>2997</ProgramServicesAmt>
        <ManagementAndGeneralAmt>5442</ManagementAndGeneralAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>8112651</TotalAmt>
        <ProgramServicesAmt>7643739</ProgramServicesAmt>
        <ManagementAndGeneralAmt>227324</ManagementAndGeneralAmt>
        <FundraisingAmt>241588</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>907961</BOYAmt>
        <EOYAmt>987114</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>7834747</BOYAmt>
        <EOYAmt>7343848</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <PledgesAndGrantsReceivableGrp>
        <BOYAmt>1127223</BOYAmt>
        <EOYAmt>1957127</EOYAmt>
      </PledgesAndGrantsReceivableGrp>
      <LandBldgEquipCostOrOtherBssAmt>9436</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>7945</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>2714</BOYAmt>
        <EOYAmt>1491</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>12401792</BOYAmt>
        <EOYAmt>13573985</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <TotalAssetsGrp>
        <BOYAmt>22274437</BOYAmt>
        <EOYAmt>23863565</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>120896</BOYAmt>
        <EOYAmt>123854</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <GrantsPayableGrp>
        <EOYAmt>4594376</EOYAmt>
      </GrantsPayableGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>120896</BOYAmt>
        <EOYAmt>4718230</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsSFAS117Ind>X</OrganizationFollowsSFAS117Ind>
      <UnrestrictedNetAssetsGrp>
        <BOYAmt>21556617</BOYAmt>
        <EOYAmt>18637431</EOYAmt>
      </UnrestrictedNetAssetsGrp>
      <TemporarilyRstrNetAssetsGrp>
        <BOYAmt>596924</BOYAmt>
        <EOYAmt>507904</EOYAmt>
      </TemporarilyRstrNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>22153541</BOYAmt>
        <EOYAmt>19145335</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>22274437</BOYAmt>
        <EOYAmt>23863565</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <InfoInScheduleOPartXIInd>X</InfoInScheduleOPartXIInd>
      <ReconcilationRevenueExpnssAmt>-3181378</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>293829</NetUnrlzdGainsLossesInvstAmt>
      <OtherChangesInNetAssetsAmt>-120657</OtherChangesInNetAssetsAmt>
      <InfoInScheduleOPartXIIInd>X</InfoInScheduleOPartXIIInd>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>0</AccountantCompileOrReviewInd>
      <FSAuditedInd>1</FSAuditedInd>
      <FSAuditedBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>1</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>0</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>3538454</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>4872354</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>3213554</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>3328828</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>4377975</CurrentTaxYearAmt>
        <TotalAmt>19331165</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>3538454</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>4872354</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>3213554</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>3328828</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>4377975</CurrentTaxYearAmt>
        <TotalAmt>19331165</TotalAmt>
      </TotalCalendarYear170Grp>
      <SubstantialContributorsTotAmt>1918154</SubstantialContributorsTotAmt>
      <PublicSupportTotal170Amt>17413011</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>189415</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>308109</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>392203</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>491655</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>350202</CurrentTaxYearAmt>
        <TotalAmt>1731584</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <OtherIncome170Grp>
        <CurrentTaxYearAmt>1336</CurrentTaxYearAmt>
        <TotalAmt>1336</TotalAmt>
      </OtherIncome170Grp>
      <TotalSupportAmt>21064085</TotalSupportAmt>
      <PublicSupportCY170Pct>0.82670</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.81700</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsCY170Ind>X</ThirtyThrPctSuprtTestsCY170Ind>
      <Form990ScheduleAPartVIGrp>
        <FormAndLineReferenceDesc>SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME:</FormAndLineReferenceDesc>
        <ExplanationTxt>MISCELLANEOUS - 2016 AMOUNT: $ 1,336.</ExplanationTxt>
      </Form990ScheduleAPartVIGrp>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>9436</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>7945</DepreciationAmt>
        <BookValueAmt>1491</BookValueAmt>
      </EquipmentGrp>
      <TotalBookValueLandBuildingsAmt>1491</TotalBookValueLandBuildingsAmt>
      <FootnoteTextInd>X</FootnoteTextInd>
      <TotalRevEtcAuditedFinclStmtAmt>5692409</TotalRevEtcAuditedFinclStmtAmt>
      <NetUnrealizedGainsInvstAmt>293829</NetUnrealizedGainsInvstAmt>
      <DonatedServicesAndUseFcltsAmt>517614</DonatedServicesAndUseFcltsAmt>
      <RevenueNotReportedAmt>811443</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>4880966</RevenueSubtotalAmt>
      <InvestmentExpensesNotIncldAmt>50307</InvestmentExpensesNotIncldAmt>
      <RevenueNotReportedFinclStmtAmt>50307</RevenueNotReportedFinclStmtAmt>
      <TotalRevenuePerForm990Amt>4931273</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>8700615</TotExpnsEtcAuditedFinclStmtAmt>
      <DonatedServicesUseFcltsAmt>517614</DonatedServicesUseFcltsAmt>
      <OtherExpensesIncludedAmt>120657</OtherExpensesIncludedAmt>
      <ExpensesNotReportedAmt>638271</ExpensesNotReportedAmt>
      <ExpensesSubtotalAmt>8062344</ExpensesSubtotalAmt>
      <InvestmentExpensesNotIncld2Amt>50307</InvestmentExpensesNotIncld2Amt>
      <ExpensesNotRptFinclStmtAmt>50307</ExpensesNotRptFinclStmtAmt>
      <TotalExpensesPerForm990Amt>8112651</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART X, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES - THE FOUNDATION RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT TO BE SUSTAINED. MANAGEMENT HAS DETERMINED THAT THE FOUNDATION HAD NO UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE FINANCIAL STATEMENT RECOGNITION OR DISCLOSURE. THE FOUNDATION IS NO LONGER SUBJECT TO EXAMINATIONS BY THE APPLICABLE TAXING JURISDICTIONS FOR TAX YEARS PRIOR TO 2013.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART XII, LINE 2D - OTHER ADJUSTMENTS:</FormAndLineReferenceDesc>
        <ExplanationTxt>UNCOLLECTIBLE PLEDGES 120,657.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleF documentId="RetDoc1040500001">
      <GrantRecordsMaintainedInd>1</GrantRecordsMaintainedInd>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>EUROPE</RegionTxt>
        <OfficesCnt>0</OfficesCnt>
        <EmployeeCnt>0</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>GRANTS</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>RESEARCH GRANT TO KAROLINSKA INSTITUTE</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>50000</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <SubtotalOfficesCnt>0</SubtotalOfficesCnt>
      <SubtotalEmployeesCnt>0</SubtotalEmployeesCnt>
      <ContinutationTotalOfficeCnt>0</ContinutationTotalOfficeCnt>
      <ContinutationTotalEmployeeCnt>0</ContinutationTotalEmployeeCnt>
      <TotalOfficeCnt>0</TotalOfficeCnt>
      <TotalEmployeeCnt>0</TotalEmployeeCnt>
      <SubtotalSpentAmt>50000</SubtotalSpentAmt>
      <ContinuationSpentAmt>0</ContinuationSpentAmt>
      <TotalSpentAmt>50000</TotalSpentAmt>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>EUROPE</RegionTxt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
        <CashGrantAmt>50000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>WIRE TRANSFER</MannerOfCashDisbursementTxt>
      </GrantsToOrgOutsideUSGrp>
      <Total501c3OrgCnt>1</Total501c3OrgCnt>
      <TotalOtherOrgCnt>0</TotalOtherOrgCnt>
      <TransferToForeignCorpInd>0</TransferToForeignCorpInd>
      <InterestInForeignTrustInd>0</InterestInForeignTrustInd>
      <ForeignCorpOwnershipInd>0</ForeignCorpOwnershipInd>
      <PassiveForeignInvestmestCoInd>0</PassiveForeignInvestmestCoInd>
      <ForeignPartnershipInd>0</ForeignPartnershipInd>
      <BoycottCountriesInd>0</BoycottCountriesInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>RESEARCH WILL BE CARRIED OUT BY THE KAROLINSKA INSTITUTE UNDER THE DIRECTION OF DR. PER SVENNINGSSON TO ELUCIDATE THE MOLECULAR MECHANISMS OF THE ACTION IN THE BRAIN RELATING TO THE CAUSE AND TREATMENT OF NEUROLOGICAL DISORDERS SUCH AS ALZHEIMER'S DISEASE. THE FOUNDATION REQUIRES THE GRANTEE TO SUBMIT AN INTERIM 6-MONTH REPORT ON THE PROGRESS OF THEIR INVESTIGATIONS AS WELL AS A FINAL REPORT UPON COMPLETION OF THE TERM OF THE AGREEMENT.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 3:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION USES THE ACCRUAL METHOD OF ACCOUNTING TO ACCOUNT FOR ITS FOREIGN EXPENDITURES.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleF>
    <IRS990ScheduleI documentId="RetDoc1041900001">
      <GrantRecordsMaintainedInd>1</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>THE ROCKEFELLER UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1230 YORK AVENUE</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10021</ZIPCd>
        </USAddress>
        <RecipientEIN>131624158</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>4594376</CashGrantAmt>
        <PurposeOfGrantTxt>SEE PART IV</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>THE ROCKEFELLER UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1230 YORK AVENUE</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10021</ZIPCd>
        </USAddress>
        <RecipientEIN>131624158</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>2000000</CashGrantAmt>
        <PurposeOfGrantTxt>SEE PART IV</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>NYU MEDICAL CENTER</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>550 FIRST AVENUE</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10016</ZIPCd>
        </USAddress>
        <RecipientEIN>135562308</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>100000</CashGrantAmt>
        <PurposeOfGrantTxt>SEE PART IV</PurposeOfGrantTxt>
      </RecipientTable>
      <Total501c3OrgCnt>2</Total501c3OrgCnt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION MONITORS THE USE OF GRANT FUNDS IN THE US BY RECEIVING PERIODIC PROGRESS REPORTS ON THE RESEARCH CONDUCTED AND ANY FINDINGS PUBLISHED AS A RESULT OF THIS FUNDING. THE FISHER CENTER FOR ALZHEIMER'S DISEASE RESEARCH AT THE ROCKEFELLER UNIVERSITY SUBMITS A REPORT AT EACH GENERAL BOARD MEETING WHICH IS INCORPORATED INTO THE MINUTES OF THE MEETING. THE FISHER EDUCATIONAL AND RESOURCES PROGRAM AT NYU SCHOOL OF MEDICINE REPORTS AT THE END OF THE FUNDING PERIOD IN THEIR REQUEST FOR FURTHER FUNDING ON THE PROGRESS TO DATE OF THE RESEARCH ACTIVITIES SUPPORTED BY THE FOUNDATION. THE FOUNDATION FUNDING DECISIONS ARE MADE UNDER THE SOLE AND ABSOLUTE DISCRETION OF THE BOARD PURSUANT TO A MAJORITY VOTE. A SCIENCE ADVISORY BOARD COMPRISED OF MEDICAL AND SCIENTIFIC EXPERTS IN THE FIELD OF ALZHEIMER'S DISEASE AND RELATED DISEASES ADVISES AND ASSISTS THE FOUNDATION IN CONNECTION WITH FUNDING GRANT REQUESTS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, SCHEDULE I, PART II, COLUMN (H):</FormAndLineReferenceDesc>
        <ExplanationTxt>PURPOSE OF GRANT THE ROCKEFELLER UNIVERSITY: GRANTS TO THE FISHER CENTER FOR ALZHEIMER'S DISEASE RESEARCH AT THE ROCKEFELLER UNIVERSITY FOR NEUROLOGICAL RESEARCH INTO THE CAUSES OF ALZHEIMER'S AND POTENTIAL NEW PHARMACOLOGICAL TREATMENT OPTIONS AND TO SUPPORT PROFESSORSHIP TO CONDUCT RESEARCH ACTIVITIES. NYU MEDICAL CENTER: NYU GRANT TO FISHER EDUCATION AND RESOURCES PROGRAM AT NY UNIVERSITY SCHOOL OF MEDICINE FOR CLINICAL RESEARCH INTO THE EFFICACY OF MEMANTINE AND COMPREHENSIVE INDIVIDUALIZED PATIENT-CENTERED MANAGEMENT OF ALZHEIMER'S DISEASE.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="RetDoc1042400001">
      <CompensationCommitteeInd>X</CompensationCommitteeInd>
      <Form990OfOtherOrganizationsInd>X</Form990OfOtherOrganizationsInd>
      <CompensationSurveyInd>X</CompensationSurveyInd>
      <BoardOrCommitteeApprovalInd>X</BoardOrCommitteeApprovalInd>
      <SeverancePaymentInd>0</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>0</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>0</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>0</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>0</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>0</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>0</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>1</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>0</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>KENT KAROSEN</PersonNm>
        <TitleTxt>PRESIDENT/CEO</TitleTxt>
        <BaseCompensationFilingOrgAmt>204996</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>78333</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>0</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>0</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>283329</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 7</FormAndLineReferenceDesc>
        <ExplanationTxt>IN 2016, THE PRESIDENT/CEO WAS AWARDED A BONUS OF $78,333 IN RECOGNITION OF HIS EXCELLENT PERFORMANCE DIRECTING THE INITIATIVES OF THE FOUNDATION, AND THE SENIOR VICE PRESIDENT CORY RYAN WAS AWARDED A BONUS OF $8,000. THE BONUSES WERE PROVIDED AT THE DISCRETION OF THE BOARD'S COMPENSATION COMMITTEE BY A UNANIMOUS VOTE.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleJ>
    <IRS990ScheduleL documentId="RetDoc1042800001">
      <BusTrInvolveInterestedPrsnGrp>
        <NameOfInterested>
          <BusinessName>
            <BusinessNameLine1Txt>CENTURY BANK</BusinessNameLine1Txt>
          </BusinessName>
        </NameOfInterested>
        <RelationshipDescriptionTxt>SEE PART V</RelationshipDescriptionTxt>
        <TransactionAmt>6002377</TransactionAmt>
        <TransactionDesc>SEE PART V</TransactionDesc>
        <SharingOfRevenuesInd>0</SharingOfRevenuesInd>
      </BusTrInvolveInterestedPrsnGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, SCHEDULE L, PART IV</FormAndLineReferenceDesc>
        <ExplanationTxt>RESULTING FROM HIGHLY COMPETITIVE RATES OFFERED BY CENTURY BANK, THE FOUNDATION HOLDS $6,002,377 IN CERTIFICATES OF DEPOSIT WITH CENTURY BANK, WHERE MR. BARRY SLOANE (THE FOUNDATION'S CHAIRMAN/TREASURER) SERVES AS PRESIDENT AND CEO. MR. BARRY SLOANE AND HIS FAMILY MEMBERS OWN MORE THAN 35% OF THE TOTAL COMBINED VOTING POWER OF THE CENTURY BANK. THE ENTIRE BOARD WAS MADE AWARE OF THE CONFLICT WITH MR. SLOANE BEFORE THE CD INVESTMENTS WERE MADE AS WELL AS A CONTINUING DISCLOSURE AT ALL SUBSEQUENT BOARD MEETINGS. THE BOARD UNANIMOUSLY VOTED TO APPROVE THE INVESTMENTS. MR. SLOANE RECUSED HIMSELF FROM THE VOTE.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleL>
    <IRS990ScheduleM documentId="RetDoc1042900001">
      <SecuritiesPubliclyTradedGrp>
        <NonCashCheckboxInd>X</NonCashCheckboxInd>
        <ContributionCnt>17</ContributionCnt>
        <NoncashContributionsRptF990Amt>153485</NoncashContributionsRptF990Amt>
        <MethodOfDeterminingRevenuesTxt>FAIR VALUE</MethodOfDeterminingRevenuesTxt>
      </SecuritiesPubliclyTradedGrp>
      <Form8283ReceivedCnt>0</Form8283ReceivedCnt>
      <AnyPropertyThatMustBeHeldInd>0</AnyPropertyThatMustBeHeldInd>
      <ReviewProcessUnusualNCGiftsInd>0</ReviewProcessUnusualNCGiftsInd>
      <ThirdPartiesUsedInd>0</ThirdPartiesUsedInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, COLUMN (B):</FormAndLineReferenceDesc>
        <ExplanationTxt>COLUMN (B) REPORTS THE NUMBER OF CONTRIBUTORS.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleM>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART I, LINE 1</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION'S FUNDING AND ACTIVITIES ARE DIRECTED TOWARDS THE CAUSE, CARE &amp; CURE OF ALZHEIMER'S DISEASE. THE FOUNDATION FUNDS RESEARCH INTO THE CAUSE AND CURE OF ALZHEIMER'S DISEASE AT THE FISHER CTR FOR ALZHEIMER'S DISEASE RESEARCH AT THE ROCKEFELLER UNIV., UNDER THE DIRECTION OF NOBEL LAUREATE DR. PAUL GREENGARD,WHOSE FINDINGS HAVE BEEN THE BASIS FOR MUCH OF TODAY'S ALZHEIMER'S INVESTIGATIONS. IT ALSO FUNDS PROJECTS FOR THE CARE OF PEOPLE WITH ALZHEIMER'S DISEASE AND THEIR CAREGIVERS AT THE FISHER ALZHEIMER'S DISEASE EDUCATION AND RESOURCES PROGRAM AT THE NEW YORK UNIVERSITY SCHOOL OF MEDICINE, UNDER THE DIRECTION OF BARRY REISBERG,MD., PROVIDING NON-PHARMACOLOGICAL TREATMENT OPTIONS TO IMPROVE CARE OF PEOPLE WITH ALZHEIMER'S. THE FOUNDATION PROVIDES EDUCATION &amp; INFORMATION TO THE PUBLIC THROUGH ITS WEBSITE WWW.ALZINFO.ORG, ITS PERIODIC MAGAZINE,PRESERVING YOUR MEMORY, AND A BI-WEEKLY E-NEWSLETTER OF THE LATEST EXPERT-REVIEWED RESEARCH FINDINGS ON CARE AND POSSIBLE TREATMENTS FOR ALZHEIMER'S.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION A, LINE 2</FormAndLineReferenceDesc>
        <ExplanationTxt>KENT KAROSEN IS A PARTNER AND EMPLOYEE OF CANTOR FITZGERALD, L.P. AND HE AND HIS ENTITIES, INCLUDING KAROSEN STRATEGIC PARTNERS, HAVE PROVIDED CONSULTING AND OTHER SERVICES FROM TIME TO TIME FOR HOWARD W. LUTNICK AND THE CANTOR ENTITIES. MR. LUTNICK ALSO SERVES AS TRUSTEE FOR CERTAIN OF MR. KAROSEN'S TRUSTS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>THE 990 IS INITIALLY REVIEWED BY MEMBERS OF THE AUDIT COMMITTEE THAT CONSISTS OF 3 INDEPENDENT TRUSTEES. A COPY OF THE 990 IS THEN FORWARDED ELECTRONICALLY VIA EMAIL TO ALL BOARD MEMBERS AND RELEVANT MANAGEMENT PERSONNEL FOR THEIR REVIEW AND COMMENT BEFORE THE 990 IS FILED. IF ANY REVISIONS ARE REQUIRED, THEY ARE MADE AND THE REVISED 990 IS RESUBMITTED TO ALL BOARD MEMBERS FOR FINAL REVIEW BEFORE FILING.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION HAS A CONFLICT OF INTEREST POLICY WHICH IS ANNUALLY MONITORED REQUIRING ALL TRUSTEES TO DISCLOSE ANY POSSIBLE CONFLICT OF INTEREST VIA EMAIL RESPONSE TO THE SENIOR VICE PRESIDENT. THE FOUNDATION REQUIRES THAT ALL TRUSTEES AND STAFF PERSONNEL PROMPTLY AND FULLY DISCLOSE ALL MATERIAL FACTS OF ANY ACTUAL OR POTENTIAL CONFLICT OF INTEREST THAT MAY EXIST AT THE TIME THE TRUSTEE IS APPOINTED OR STAFF PERSONNEL IS HIRED, OR AS THEY MAY ARISE WHILE THE TRUSTEE IS SERVING ON THE BOARD OR THE STAFF PERSONNEL IS EMPLOYED BY THE FOUNDATION. SUCH DISCLOSURES INVOLVING A TRANSACTION, ARRANGEMENT OR DECISION BEING CONSIDERED BY THE BOARD ARE MADE KNOWN TO ALL TRUSTEES. THE BOARD THEN DETERMINES WHETHER A CONFLICT OF INTEREST EXISTS WITH THE INTERESTED PARTY ABSTAINING FROM THE DECISION. IF IT IS DETERMINED THAT NO CONFLICT EXISTS, THEN THE BOARD VOTES ON THE TRANSACTION BUT WITH THE INTERESTED PARTY RECUSING HIMSELF FROM THE DISCUSSION AND VOTE ON SAID MATTER.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 15</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION HAS A COMPENSATION COMMITTEE CONSISTING OF 4 INDEPENDENT TRUSTEES TO DETERMINE THE COMPENSATION OF THE PRESIDENT/CEO, SENIOR VICE PRESIDENT AND TOP MANAGEMENT AND KEY EMPLOYEES AT LEAST ONCE A YEAR.THE COMMITTEE IS MANDATED BY ITS CHARTER TO REVIEW EXECUTIVE AND OTHER KEY EMPLOYEE PERFORMANCE CONSISTENT WITH THE GOALS AND OBJECTIVES OF THE FOUNDATION AS DETERMINED BY THE BOARD OF TRUSTEES AND TO DETERMINE AN APPROPRIATE LEVEL OF COMPENSATION IN LIGHT OF THIS PERFORMANCE REVIEW AND USING OTHER SUBSTANTIATING DATA SURVEYS ON CURRENT COMPENSATION RATES FOR SIMILAR POSITIONS IN OTHER COMPARABLE NONPROFITS IN THE NEW YORK CITY AREA.THE COMMITTEE'S DECISION IS DOCUMENTED IN A CONTEMPORANEOUSLY WRITTEN FORMAT (COMPENSATION COMMITTEE MINUTES) INDICATING THE DATE OF THE MEETING, THE MEMBERS PRESENT, AND THE COMPARABLE DATA USED TO MAKE THE DECISION.THE COMPENSATION REVIEW PROCESS FOR THE PRESIDENT/CEO AND EXECUTIVE VICE PRESIDENT WAS LAST UNDERTAKEN ON NOVEMBER 22, 2016.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION C, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION MAKES ITS FORM 990 AND AUDITED FINANCIAL STATEMENTS AVAILABLE FOR PUBLIC INSPECTION AS REQUIRED UNDER SECTION 6104 OF THE INTERNAL REVENUE CODE BY POSTING IT ON THEIR WEBSITE AS WELL AS OTHER SIMILAR WEBSITES SUCH AS WWW.GUIDESTAR.ORG. IN ADDITION, THE FORM 990 AND AUDITED FINANCIAL STATEMENTS, CONFLICT OF INTEREST POLICY AND OTHER POLICIES ARE AVAILABLE UPON WRITTEN REQUEST AT 110 E. 42ND STREET, FL 16, NEW YORK, NY 10017 OR BY CALLING THE ORGANIZATION DIRECTLY AT (800) 259-4636 OR (212) 915-1321.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART XI, LINE 9:</FormAndLineReferenceDesc>
        <ExplanationTxt>UNCOLLECTIBLE PLEDGES -120,657.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART XII, LINE 2C:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION HAS AN AUDIT COMMITTEE THAT IS RESPONSIBLE FOR OVERSIGHT OF THE AUDIT AND ITS FINANCIAL STATEMENTS AND SELECTION OF AN INDEPENDENT ACCOUNTANT. THE PROCESS HAS NOT CHANGED FROM THE PREVIOUS YEAR.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>